# NoYA RAISE Trial II (Radiofrequency Ablation-Based Interatrial Shunt for Heart Failure)

Study · id `cardio:ct-nct05375110` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05375110](<https://clinicaltrials.gov/study/NCT05375110>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05375110

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT05375110. Allocation not applicable; no masking; primary purpose treatment. Start 2021-03-10 (actual); primary completion 2022-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT05375110, source copy `cardio:ctgov-nct05375110-2022-05-16`, retrieved 2026-10-26)
- Started: 2021-03-10 (actual) (ClinicalTrials.gov record NCT05375110, source copy `cardio:ctgov-nct05375110-2022-05-16`, retrieved 2026-10-26)
- Primary completion: 2022-12-31 (anticipated) (ClinicalTrials.gov record NCT05375110, source copy `cardio:ctgov-nct05375110-2022-05-16`, retrieved 2026-10-26)
- Completion: 2023-12-31 (anticipated) (ClinicalTrials.gov record NCT05375110, source copy `cardio:ctgov-nct05375110-2022-05-16`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05375110, source copy `cardio:ctgov-nct05375110-2022-05-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05375110-2022-05-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: NoYA RAISE Trial II (Radiofrequency Ablation-Based Interatrial Shunt for Heart Failure)
- Condition: Heart Failure
- Intervention (Device): NoYA™ Radiofrequency Interatrial Shunt System
- Lead sponsor: Hangzhou NOYA MedTech Co. Ltm.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: ed829a0dd19877a5a0ca6cf5b4ad47044dff4a323bbbd70c765676f74a54c365
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
